Instrument Inactif

Autres langues Flexion Therapeutics, Inc.

Actions

FLXN

US33938J1060

Recherche biotechnologique et médicale

Autres langues

28/03/22	Renovacor Names New CFO
07/12/21	Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
19/11/21	FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, (form 8-K)
19/11/21	Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from NASDAQ Composite Index
19/11/21	Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P Global BMI Index
19/11/21	Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P TMI Index
19/11/21	Pacira BioSciences, Inc. completed the acquisition of Flexion Therapeutics, Inc..
18/11/21	Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from NASDAQ Biotechnology Index
12/11/21	FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
12/11/21	Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
12/10/21	FLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN
12/10/21	FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)
11/10/21	NASDAQ 100 : Top Midday Gainers
11/10/21	DJ Industrial : Wall Street Declines on Soaring Energy Prices
11/10/21	Flexion Therapeutics : Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell
11/10/21	DJ Industrial : Top Premarket Gainers
11/10/21	Pacira BioSciences : adds non-opioid pain drugs with $427.5 million Flexion buy
11/10/21	Pacira BioSciences : to buy Flexion for $427.5 million
11/10/21	Pacira BioSciences, Inc. entered into a definitive Agreement and Plan of Merger to acquire Flexion Therapeutics, Inc. for approximately $440 million.
01/10/21	Flexion Therapeutics : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/09/21	Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P Biotechnology Select Industry Index
08/09/21	Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
06/09/21	Flexion Therapeutics : to Present at the Wells Fargo 2021 Virtual Healthcare Conference
03/09/21	Flexion Therapeutics : Announces Inclusion of ZILRETTA in American Academy of Orthopaedic Surgeons (AAOS) Clinical Practice Guidelines for the Management of Osteoarthritis of the Knee
03/09/21	Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference